Medical Condition News

RSS

'Spongy' silicon biosensor shows promise for medical, security applications

Vanderbilt University engineers have created a "spongy" silicon biosensor that shows promise not only for medical diagnostics, but also for the detection of dangerous toxins and other tiny molecules in the environment.

27 May 2011

Difficulty to learn maths linked to neurocognitive disorder

Students who struggle to learn mathematics may have a neurocognitive disorder that inhibits the acquisition of basic numerical and arithmetic concepts, according to a new paper by University of Minnesota and British researchers. Called developmental dyscalculia, the disorder affects roughly the same number of people as dyslexia but has received much less attention (and research funding).

27 May 2011

Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA

Data presented today at the EULAR 2011 Annual Congress demonstrated that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, and may also offer the opportunity to change future treatment options for some.

27 May 2011

Disparities based on race and ethnic origin exist in every aspect of stroke care

Disparities between racial/ethnic minorities and whites cross all aspects of stroke care, according to an American Heart Association/American Stroke Association scientific statement.

27 May 2011

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

The National Heart, Lung, and Blood Institute of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke.

27 May 2011

Research provides new understanding of how heroin affects the brain

New research from the Norwegian Institute of Public Health suggests that our understanding of how heroin affects the brain should be changed. A new report shows that heroin is metabolised to 6-MAM which then crosses the blood-brain barrier to cause the intoxicating effects that arise shortly after heroin administration.

27 May 2011

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.

27 May 2011

Insight into new prion formation

Unlocking the mechanisms that cause neurodegenerative prion diseases may require a genetic key, suggest new findings reported by University of Illinois at Chicago distinguished professor of biological sciences Susan Liebman.

27 May 2011

Leukemia, psoriasis drugs may treat vascular diseases

A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke.

27 May 2011

Exposure to pesticides near any workplace increases risk of Parkinson's disease

In April 2009, researchers at UCLA announced they had discovered a link between Parkinson's disease and two chemicals commonly sprayed on crops to fight pests.

27 May 2011

Biosign to demonstrate latest generation medical measurement system at International MeMeA symposium

Biosign Technologies Inc. announced today that it will introduce its latest generation medical measurement system, the UFIT TEN-20, at the International Symposium on Medical Measurements and Applications, being held in Italy by the Institute of Electrical and Electronics Engineers on May 30-31, 2011. Dr Radu Leca, Biosign's CEO, will speak and demonstrate the system during the Plenary Session - Invited Lecture "Issues in Medical Measurement".

27 May 2011

ViroPharma launches documentary film on hereditary angioedema

ViroPharma Incorporated today announced the launch of the documentary Swell, a twenty-five minute film that allows families dealing with the rare genetic swelling disease, hereditary angioedema, to share the challenges and triumphs of living with a chronic disorder.

27 May 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.

27 May 2011

ARCA plans to expand development program for Gencaro in atrial fibrillation

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial fibrillation, a disease that affects more than 2.4 million patients in the United States.

27 May 2011

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

27 May 2011

Southern U.S. Stroke Belt population have greater incidence of cognitive decline

New research shows that residents of the Stroke Belt—a southern portion of the U.S. with significantly elevated stroke morality rate—also have a greater incidence of cognitive decline than other regions of the country.

27 May 2011

Researchers find mechanism of action for cancer-killing peptides

Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria.

27 May 2011

Tacrolimus prevents breast cancer growth in pre-clinical studies

Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.

27 May 2011

Research sheds light on how painkillers could prevent or slow down cancer growth

CANCER RESEARCH UK scientists have shed light on how a common class of painkillers - which includes ibuprofen - may interact with a key protein that fuels the growth of many different types of cancer, according to a study published in the journal Chemical Communications today.

27 May 2011

New genomics research on abnormal brain development

Local researchers are finally on the road to developing targeted treatments for serious, life-long disabilities such as autism and schizophrenia, thanks to new genomics research focusing on abnormal brain development.

27 May 2011

Medical Condition News

'Spongy' silicon biosensor shows promise for medical, security applications

Difficulty to learn maths linked to neurocognitive disorder

Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA

Disparities based on race and ethnic origin exist in every aspect of stroke care

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

Research provides new understanding of how heroin affects the brain

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Insight into new prion formation

Leukemia, psoriasis drugs may treat vascular diseases

Exposure to pesticides near any workplace increases risk of Parkinson's disease

Biosign to demonstrate latest generation medical measurement system at International MeMeA symposium

ViroPharma launches documentary film on hereditary angioedema

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

ARCA plans to expand development program for Gencaro in atrial fibrillation

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Southern U.S. Stroke Belt population have greater incidence of cognitive decline

Researchers find mechanism of action for cancer-killing peptides

Tacrolimus prevents breast cancer growth in pre-clinical studies

Research sheds light on how painkillers could prevent or slow down cancer growth

New genomics research on abnormal brain development

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News